A detailed history of Vivo Capital, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 6,756,756 shares of ERAS stock, worth $17.4 Million. This represents 2.7% of its overall portfolio holdings.

Number of Shares
6,756,756
Previous 6,756,756 -0.0%
Holding current value
$17.4 Million
Previous $15.9 Million 15.68%
% of portfolio
2.7%
Previous 2.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.63 $12.1 Million - $17.8 Million
6,756,756 New
6,756,756 $15.9 Million

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $314M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.